Literature DB >> 17408778

Cardiovascular prognostic value of vascular involvement in Behcet's disease.

Mustafa Caliskan1, Hakan Gullu, Sema Yilmaz, Ozgur Ciftci, Dogan Erdogan, Recep Dursun, Eftal Yucel, Haldun Muderrisoglu.   

Abstract

We measured carotid artery intima-media thickness (IMT), brachial artery flow mediated dilation (FMD), and coronary flow reserve (CFR) in 38 Behcet's disease (BD) patients without vascular involvement, 15 BD patients with vascular involvement, and 35 control subjects. BD patients with and without vascular involvement were similar regarding carotid IMT (0.52+/-0.14; 0.51+/-0.09; 0.46+/-0.09; P=0.051), and brachial FMD (16.3+/-6.8; 16.5+/-9.1). CFR values were significantly impaired in BD patients compared to the controls; however the BD patients with and without vascular involvement were similar regarding CFR (2.66+/-0.45; 2.62+/-0.48; 2.91+/-0.53, P=0.007 with and without vascular involvement and the controls, respectively). Endothelial and coronary microvascular functions are compromised in BD patients without vascular involvement as remarkably as that in patients with vascular involvement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408778     DOI: 10.1016/j.ijcard.2007.01.057

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis.

Authors:  Gian Luca Erre; Giorgio Buscetta; Panagiotis Paliogiannis; Arduino Aleksander Mangoni; Ciriaco Carru; Giuseppe Passiu; Angelo Zinellu
Journal:  Rheumatol Int       Date:  2018-05-07       Impact factor: 2.631

Review 2.  Cardiac Function and Diastolic Dysfunction in Behcet's Disease: A Systematic Review and Meta-Analysis.

Authors:  Fawad Aslam; Salman J Bandeali; Cynthia Crowson; Mahboob Alam
Journal:  Int J Rheumatol       Date:  2016-05-10

3.  Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease.

Authors:  Akihiro Nakamura; Tomoya Miyamura; Eiichi Suematsu
Journal:  Case Rep Rheumatol       Date:  2016-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.